Cargando…
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/ https://www.ncbi.nlm.nih.gov/pubmed/33429060 http://dx.doi.org/10.1016/j.clim.2021.108665 |
_version_ | 1783641985899298816 |
---|---|
author | Talotta, Rossella |
author_facet | Talotta, Rossella |
author_sort | Talotta, Rossella |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7833091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78330912021-01-26 Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” Talotta, Rossella Clin Immunol Letter to the Editor Elsevier Inc. 2021-03 2021-01-08 /pmc/articles/PMC7833091/ /pubmed/33429060 http://dx.doi.org/10.1016/j.clim.2021.108665 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Talotta, Rossella Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title | Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title_full | Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title_fullStr | Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title_full_unstemmed | Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title_short | Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
title_sort | do covid-19 rna-based vaccines put at risk of immune-mediated diseases? in reply to “potential antigenic cross-reactivity between sars-cov-2 and human tissue with a possible link to an increase in autoimmune diseases” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/ https://www.ncbi.nlm.nih.gov/pubmed/33429060 http://dx.doi.org/10.1016/j.clim.2021.108665 |
work_keys_str_mv | AT talottarossella docovid19rnabasedvaccinesputatriskofimmunemediateddiseasesinreplytopotentialantigeniccrossreactivitybetweensarscov2andhumantissuewithapossiblelinktoanincreaseinautoimmunediseases |